about
Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth.Identifying predictors of early growth response and adverse radiation effects of vestibular schwannomas to radiosurgeryThe molecular biology of vestibular schwannomas and its association with hearing loss: a review.Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1): Analysis in 5536 Cases Revealed Consistent Expression in Trophoblastic Tumors.A Unified Methodological Framework for Vestibular Schwannoma Research.Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors.
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
B7-H1 expression in vestibular schwannomas.
@ast
B7-H1 expression in vestibular schwannomas.
@en
type
label
B7-H1 expression in vestibular schwannomas.
@ast
B7-H1 expression in vestibular schwannomas.
@en
prefLabel
B7-H1 expression in vestibular schwannomas.
@ast
B7-H1 expression in vestibular schwannomas.
@en
P2093
P2860
P1476
B7-H1 expression in vestibular schwannomas.
@en
P2093
Brian A Neff
Colin L W Driscoll
David J Archibald
Eugene D Kwon
Haidong Dong
Michael J Link
Patrick L Splinter
Stephen G Voss
P2860
P304
P356
10.1097/MAO.0B013E3181E40E4F
P577
2010-08-01T00:00:00Z